Uterine artery embolization for the treatment of adenomyosis: a review
review
OA: bronze
public-domain-us
AI-generated summary
Uterine artery embolization treatment for adenomyosis showed significant short- and long-term clinical and symptomatic improvements in 75.7% of patients across 15 studies with a median follow-up of 26.9 months.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
During the past 10 years, uterine artery embolization (UAE) has been investigated as a possible therapy for adenomyosis. All publications available from 1999 through 2010 are included in this report. Levels of evidence and trial classifications were evaluated according to the guidelines developed by the United States Preventive Services Task Force. Long-term data are available from 511 affected women from 15 studies. Improvements were reported by 387 patients (75.7%). The median follow-up was 26.9 months. UAE as treatment for adenomyosis shows significant clinical and symptomatic improvements on a short- and long-term basis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cited by (1)
Cited by (1)
Source provenance
- europepmc
- last seen: 2026-08-09T06:10:49.860119+00:00
- pubmed
- last seen: 2026-05-13T22:16:42.478857+00:00
- unpaywall
- last seen: 2026-05-14T19:30:52.867331+00:00
License: public-domain-us
· commercial use OK
· attribution required
Courtesy of the U.S. National Library of Medicine
Courtesy of the U.S. National Library of Medicine